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Abstract
Background: Depression is highly prevalent among Haemodialysis (HD) patients and is known to results in a series
of adverse outcomes and poor quality of life (QoL). Although cognitive behavioural therapy (CBT) has been shown
to improve depressive symptoms and QoL in other chronic illness, there is uncertainty in terms of the effectiveness
of CBT in HD patients with depression or depressive symptoms.
Methods: All randomised controlled trials relevant to the topic were retrieved from the following databases:
CINHAL, MEDLINE, PubMed, PsycINFO and CENTRAL. The grey literature, specific journals, reference lists of included
studies and trials registers website were also searched. Data was extracted or calculated from included studies that
had measured depression and quality of life using valid and reliable tools –this included mean differences or
standardised mean differences and 95% confidence intervals. The Cochrane risk of bias tool was used to identify
the methodological quality of the included studies.
Results: Six RCTs were included with varying methodological quality. Meta-analysis was undertaken for 3 studies that
employed the CBT versus usual care. All studies showed that the depressive symptoms significantly improved after the
CBT. Furthermore, CBT was more effective than usual care (MD = − 5.28, 95%CI − 7.9 to − 2.65, P = 0.37) and
counselling (MD = − 2.39, 95%CI − 3.49 to − 1.29), while less effective than sertraline (MD = 2.2, 95%CI 0.43 to 3.97) in
alleviating depressive symptoms. Additionally, the CBT seems to have a beneficial effect in improving QoL when
compared with usual care, while no significant difference was found in QoL score when compared CBT with sertraline.
Conclusions: CBT may improve depressive symptoms and QoL in HD patients with comorbid depressive symptoms.
However, more rigorous studies are needed in this field due to the small quantity and varied methodological quality
in the identified studies.
Keywords: Haemodialysis, Cognitive behavioural therapy, Depression, Quality of life
© The Author(s). 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License,
which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if
changes were made. The images or other third party material in this article are included in the article's Creative Commons
licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons
licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain
permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the
data made available in this article, unless otherwise stated in a credit line to the data.
* Correspondence: Chen.Ling@mail.bcu.ac.uk
Chen Ling is the first author; Debra Evans is the joint first author
1Department of Nephrology, Huadu Hospital, Southern Medical University
(People’s Hospital of Huadu District), 22 Baohua Road, Huadu District,
Guangzhou 510800, People’s Republic of China
2The Third School of Clinical Medicine, Southern Medical University,
Guangzhou, People’s Republic of China
Full list of author information is available at the end of the article
Ling et al. BMC Psychiatry          (2020) 20:369 
https://doi.org/10.1186/s12888-020-02754-2
Background
End stage renal disease (ESRD) is a leading cause of
morbidity and mortality worldwide, and it has a sharply
increasing incidence and prevalence. Globally, the num-
ber of ESRD patients was 2.62 million in 2010 [1] and it
is predicted to increase to more than double by 2030 to
5.4 million [2]. The increased ESRD prevalence is pre-
dominantly due to the incidence of diabetes and hyper-
tension stay high and show an increasing trend [3].
Currently, HD is the mainstream treatment for ESRD
patients, and 90% of them are receiving this therapy
worldwide [4].
Depression is a prominent psychological problem in
HD patients. It is estimated that HD patients have an
approximately four-fold incidence of depression com-
pared to the general population [5]. A multinational
cross-sectional study found that the prevalence of de-
pression was up to 46% from 2278 HD participants [6].
The depression symptoms of HD patients are associated
with a series of adverse outcomes, for instance, lower
treatment compliance [7, 8], malnutrition, increased
morbidity [9], decreased quality of life, higher rates of
hospitalisation and mortality among HD patients [10–
12]. However, depression issues are often under recog-
nized and untreated [13]. Therefore, these severe
outcomes indicated the importance of monitoring the
mental state of the patients as well as the necessity of
providing effective treatments for patients with HD.
CBT is one of the most widely practised therapeutic
approaches in psychology. CBT reduces depressive
symptoms by identifying inaccurate and maladaptive
cognitions, testing the cognitions against reality, and
modifying the dysfunctional thoughts, emotions and be-
haviours through different strategies accordingly [14].
The standard techniques of CBT which are utilised in
treating depression are divided into two parts. The cog-
nitive techniques include cognition identification,
thought recording, cognition restructuring, thought testing
and distraction strategy training [15, 16]. The behavioural
techniques consist of goal setting, activity scheduling, relax-
ation training and relapse prevention [17].
NICE clinical guideline [18] recommended CBT as a
therapy for depression in people with chronic diseases.
Subsequently, growing evidence has been shown that CBT
is a well-established intervention in depression in different
chronic diseases, such as diabetes, hypertension, heart fail-
ure co-morbid depression patients [19–21]. It also has a
promising effect on some patients’ QoL. However, the ef-
fects of CBT on HD patients with depression remains un-
clear because there is no systematic review that
specifically targets this issue.
Previously, there were three systematic reviews [22–24]
that investigated the effects of psychological therapies on
depression in HD and Chronic kidney disease patients.
While these reviews included CBT studies, due to small
quantity of the included articles of CBT and the included
patients were not required to be assessed by the validated
depression scales, there is a lack of conclusion which spe-
cifically emphasises the effect of CBT. The authors of the
systematic reviews also recommended that certain types
of psychological interventions could be investigated to
reach more reliable conclusions [22]. Given that new
RCTs have emerged after these three systematic reviews,
there is a need to upgrade the evidence to assess the im-
pact of CBT on patients’ reported measures of depression
and QoL in individuals with HD.
In the present systematic review, randomised con-
trolled trials (RCTs) were included exclusively. A rando-
mised controlled trial is a type of scientific experiment
that randomly allocating subjects to two or more groups,
treating them differently, and then comparing them with
respect to a measured response. Due to the randomised
allocating process, this type of trial can reduce certain
sources of bias, such as selection bias, when testing the
effectiveness of treatments.
Methods
This article adherences to the PRISMA guidelines [25]
for systematic review. The PRISMA checklist for this
systematic review is presented in Additional file 1 (sup-
plementary material).
Criteria for considering studies for this systematic review
The type of studies conducted
Randomised controlled trials.
The type of participants involved
Participants were limited to adult patients (aged 18 years
and over) with HD treatment (more than 3 months) and
depression or depressive symptoms. Studies were in-
cluded if participants who had depression or depressive
symptoms were assessed by investigators using struc-
tured clinic interview (DSM) or validated depression
scales. Studies whose patients had cognitive dysfunction
were excluded because they could not understand and
follow the procedures of CBT.
The type of interventions and comparison intervention used
The intervention of interest in this systematic review
was CBT or CBT-based intervention. The included stud-
ies had to entail both cognitive and behavioural compo-
nents, such as cognitive restructuring, behavioural
activation, muscle relaxation and deep breathing. Studies
which solely comprise cognitive therapy or behavioural
therapy were excluded because they did not belong to
the definition of CBT.
The intervention in included articles was CBT con-
ducted by therapists or professional nurse or in a
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computerised CBT. The formats of CBT could be deliv-
ered individually (by telephone or face-to-face) or in
groups. The comparison interventions could include no
treatment, usual care, waiting lists and any other
therapies.
The type of outcome measured
The outcomes of interest in this systematic review were
depression and QoL among HD patients. There was no
limitation on the types of validated scales relevant to de-
pression and QoL.
Language, full-text availability and the timeline of the
studies
Studies included in this review were required to be
the English language and full-text articles. Only stud-
ies undertaken from January 1976 were included in
this systematic review. According to Silverstein [26],
thrice-weekly HD treatment has over four decades of
routine access and clinical experience for adult HD
patients. This means that the regular maintenance
HD was started in 1976. The history of CBT can be
traced back to the 1960s [27], which was longer than
the maintenance HD treatment. Therefore, the
present author identified the search dates range from
January 1976 to July 2019.
Search strategy
Electronic database search
Index term, such as Medical Subject Headings (MeSH)
and free texts were used to ensure a comprehensive and
specific search. The identified key search terms were
“haemodialysis”, “cognitive behaviour therapy”, “cogni-
tive therapy”, “behavioural therapy” and “depression”.
The corresponding synonyms, abbreviations and trunca-
tions were utilised to expand the search range also. The
full electronic search strategy is presented in Additional
file 2 (supplementary material).
The following electronic databases were visited to
identify the relevant RCTs: CINHAL, MEDLINE, Psy-
cINFO, PubMed, CENTRAL (from 1st April 2019 up to
4th July 2019). The search record of CINHAL is at-
tached in Additional file 3 (supplementary material)
Complementary search
The present author searched some specialist journals,
such as Journal of Renal Care; BMC Nephrology; Inter-
national Urology and Nephrology; American Journal of
Kidney Diseases; Hemodialysis International. Also, the
present author browsed the reference lists of relevant
systematic reviews and all included studies to identify
additional articles that might have been missed from an
electronic search.
Grey literature To find as much evidence as possible,
http://ethos.bl.uk/, www.opengrey.eu/ and https://
scholar.google.com/ were searched to identify relevant
dissertations, conference abstracts or other research
papers.
To ascertain the conclusions of the systematic review
were as up to date as possible, the present author
searched the trials registers website, such as www.Clini-
calTrials.gov.
Study selection procedures
There were two stages of selection work. The first stage
was reviewing the title and abstract. Initially, all the
search results from different databases were downloaded
into Endnote Version 9.0 software. Duplicate literature
records were removed by the software. Then, all the ti-
tles and abstracts of the imported literature were
scanned by the present author. The standard of the
reviewing was based on the population, intervention,
comparative intervention, outcome and type of study.
Articles that were not relevant to the topic of the sys-
tematic review were excluded. For those articles that
met the inclusion criteria, or they did not provide
enough information in the abstract, the full-text articles
were required. If the full text of research could not be
obtained after contacting the article author, applying for
the inter-library loans service, or using any other
methods, the articles were excluded. Those obtained
full-text articles were brought into the next stage of
selection.
The second stage was reviewing the full-text paper.
The standard of the reviewing was based on the inclu-
sion criteria and exclusion criteria. For the studies which
could not be determined by the author, they were dis-
cussed with the second author to achieve a consensus
result. The selection of articles was followed with the
PRISMA flowcharts and presented with a diagram.
Quality assessment
The Cochrane risk of bias tool was used to assess the
potential bias in the studies included in the present sys-
tematic review. Included studies were assessed via six
domains, including selection bias, performance bias, de-
tection bias, attrition bias, reporting bias and other bias.
The results of the assessment were expressed as low bias
risk, high bias risk and unclear bias risk. RevMan 5.3
software was used to present the results of the quality
assessment more visually.
Data extraction
A pre-designed data extraction form was employed to
collect relevant and necessary information of included
studies. The data to be extracted include details of study
information (authors, published year country and
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publication), methods (aims of the study, study design,
setting), participants (sample size and allocation, drop
out, mean age, gender, inclusion criteria, and exclusion
criteria), interventions (including descriptions of the im-
plementation process of CBT and counter-intervention,
frequency and length of intervention, length of follow-
up, amount of contact, adverse effects and deliverers),
outcomes (primary and secondary outcomes specified
and collected), results (the depression and QoL scores at
baseline, post-intervention and follow-up), conclusions
and the results of the assessment of the risk of biases.
Data synthesis
In this systematic review, the included comparison inter-
ventions were usual care, no intervention and any other
therapies. Due to the diversity of interventions included,
narrative synthesis combined with meta-analyses may be
used in the present review. To measure the clinical ef-
fectiveness of the intervention, mean differences (MD)
and the corresponding 95% confidence intervals (CI)
were calculated. To assess the heterogeneity among
studies, chi-square test and I2 were utilised. If the tested
heterogeneity is not significant (P ≥ 0.1, I2 ≤ 50), the
fixed-effect model can be used. If the tested heterogen-
eity is distinct (P<0.1, I2>50), the random effect model
can be used in meta-analysis [28]. The amount of het-
erogeneity was evaluated visually by conducting a forest
plot [29].
Results
Results of the search strategy
The initial search of electronic databases yielded a total
of 1056 records, and 3 records were identified through
other resources. After the removal of duplicate studies
and careful appraisal of titles, abstracts and full-text, 6
articles were included in the present systematic review.
The process of literature retrieval is summarised in Fig. 1
below. The characteristics of excluded studies are sum-
marised in Additional file 4 (supplementary material).
Characteristics of included studies
A total of six RCTs and 479 participants were included
in the current review (248 in CBT groups, 231 in control
groups). The studies all published between 2009 and
2019. The sample sizes ranging from 49 to 116 patients
per study. In this population, 51.6% of the participants
were males whilst 48.4% of them were females. Studies
specifically recruited adult patients over 18 years old,
and the mean age of this population ranged from 41.7 to
54.0.
All studies included HD participants with depressive
symptoms, while with different criteria. The inclusion
criteria, characteristics of the population and baseline
are summarised in Table 1 below. According to the
scoring instructions of different depression scales and
the baseline depression score, the included participants
were assessed as mild to moderate depression before the
treatment in Lerma et al.’s study [30]; moderate depres-
sion in four studies [31–34]; and moderate to severe de-
pression in Al saraireh et al.’s study [35]. The depressive
symptoms in above studies were measured by the Beck
Depression Inventory (BDI), Hamilton Depression Rat-
ing Scale (HDRS), Mini International Neuropsychiatric
Interview (MINI), Hospital Anxiety and Depression
Scale (HADS) and Quick Inventory of Depressive
Symptoms-Clinician-rated (QIDS-C).
Details of study interventions and comparisons
All the intervention groups included both the cognitive
and behaviour elements. Moreover, all of the studies
used a face-to-face method to conduct CBT. However,
these CBT were varied in format, delivery and duration.
In four studies, the CBT interventions were conducted
by individual format [32–35]. The remaining two studies
evaluated group CBT programmes, each group consist-
ing of 3–6 patients [30, 31]. Overall, the duration of
CBT varied from 5 weeks to 12 weeks, and the study
follow-up period ranged from 1 month to 6 months after
the post-treatment. Each weekly session lasted 1 h to 2
h. The interventions were delivered by psychologists,
therapists without description, or nurses who had CBT
expertise.
In the comparison groups, three studies compared
CBT against usual care (also sometimes described in tri-
als as treatment as usual or waiting list) [30–32]. The
remaining three studies compared CBT with active com-
parisons groups comprising counselling [33], psychoedu-
cation [35] and antidepressants [34]. Table 2 provides
the detailed characteristics of the included studies below.
Results of study quality assessment
Figure 2 and Fig. 3 below present a summary of the risk
of bias across studies.
Random sequence generation
All studies were described as “randomised”, and five of
the six studies reported adequate information about ran-
domisation. However, one study [32] was rated as un-
clear because there were insufficient details about the
methods of randomisation.
Allocation concealment
Four studies [30, 32, 34, 35] failed to state the detailed
information of allocation concealment. Therefore, these
four studies were rated unclear by default. Two studies
[31, 33] used sealed envelopes to conceal the assign-
ments, which in turn avoids selection bias. Hence, these
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two studies were rated as at low risks of allocation
concealment.
Blinding of participants and personnel
Given the nature and method of implementation of
CBT, it was impossible to keep the persons receiving or
delivering the intervention or usual care blinded. There-
fore, all studies were at high risk of performance bias.
Blinding of outcome assessment
In the six studies, four articles explicitly stated the blind-
ing of outcome assessors [30–32, 34]. Hence, they were
at low risk of detection bias. There was no description of
the blinding of outcome assessment in the remaining
two studies [33, 35]. Hence, the detection bias was rated
as unclear in these two studies.
Incomplete outcome data
Four studies [30–32, 34] were rated as low risk of attri-
tion bias due to the relatively low and balanced dropout
rates, and clearly stated reasons. Valsara et al.’s study
[33] failed to report the reasons for dropout. Therefore,
the attrition bias of Valsara et al.’s study was considered
as unclear. One study had higher attrition rates (CBT
group was 21.6%, while 25.9% in the psychoeducation
group) [35]. Therefore, Al saraireh et al.’s study [35] was
rated as at high attrition risk.
Selective reporting
One trial protocol was published in Mehrotra et al.’s
study [34]. All the outcomes were reported as planned.
For the other five articles, selective reporting bias was
not able to be assessed due to a lack of published proto-
cols. Therefore, the methodologies and results sections
Fig. 1 PRISMA Flowchart for search result. Detailed legend: The initial search of electronic databases yielded a total of 1056 records, and 3
records were identified through other resources. After the removal of duplicate studies and careful appraisal of titles, abstracts and full-text, 6
articles were included in the present systematic review
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of these five studies were carefully scanned to find in-
complete data reports. All of the articles reported the
pre-set outcomes. Hence, the rest of the five studies
were rated as at low reporting bias.
Effects of the intervention
The summary of the outcomes and effects of the inter-
ventions are elaborated in Table 3 below.
CBT vs usual care
Three studies compared CBT versus usual care at post-
treatment and follow-up.
Reduction in depressive symptoms Post-treatment
The meta-analyses of the three CBT versus usual care
studies for depression are shown in Fig. 4. The CBT
studies favoured the direction of the intervention,
showing improvements in symptoms of depression
(MD = − 5.28, 95% CI − 7.9 to − 2.65, p = 0.37).
Lerma et al.’s study [30] conducted five weekly CBT
sessions. The calculated MD was − 4.8 (95%CI − 10.6 to
1.00), meaning that the difference in depressive symp-
toms mean scores between the CBT and usual care was
not statistically significant (Fig. 5). In Cukor et al.’s [32]
and Duarte et al.’s [31] studies, they all conducted 12
weeks of CBT. Duarte et al.’s study demonstrated the
significant differences in favour of CBT (MD = − 7.1,
95%CI − 10.88 to − 3.32). Upon a closer looking in
Duarte et al.’s study and compared the data between
baseline (Table 2 above) and post-treatment, the depres-
sion level gradually decreased from moderate depression
to mild depression in CBT group (baseline:24.2 ± 9.7,
post-treatment: 14.1 ± 8.7, P<0.001). Conversely, the
patients in the usual care group stayed in moderate de-
pression level after the treatment (baseline:27.3 ± 10.7,
post-treatment: 21.2 ± 9.1, P<0.001).
However, Cukor et al. ‘s [32] study showed no differ-
ence between the CBT and usual care (MD = − 2.8,
95%CI − 7.47 to 1.87) (Fig. 4). A more in-depth look at
the baseline and post-treatment depression scores, the
depression level of both groups changed from moderate
to mild depression (post-treatment in CBT group:
11.7 ± 9.8; post-treatment in usual care group: 14.5 ±
8.5). Additionally, Cukor et al.’s [32] study also used the
HAM-D scale to test the effectiveness of CBT. Com-
pared with the non-significant results measured by BDI,
the results measured by HAM-D scales showed a signifi-
cant difference in favour of CBT compared with usual
care (MD = -4.4, 95%CI − 7.51 to − 1.29). Furthermore,
the depression level reduced significantly from moderate
depression to normal condition in the CBT group, while
the participants in the control group stayed a mild de-
gree of depression using the HAM-D tool.
Follow-up
The meta-analyses of the three CBT versus usual care
studies for depression are shown in Fig. 5. The CBT
studies favoured the direction of the intervention,
showing improvements in symptoms of depression
Table 1 Characteristics of study design, inclusion criteria, population and baseline
Study ID Study
design
Inclusion criteria Sample size
(I/C), male %
Mean age Dropouts Baseline depression
score Mean (SD)
Duarte (2009) [31] RCT age:18-80
HD>3 months
Mini International
Neuropsychiatric
Interview≥5
85 (41/44)
Male: 35 (38.9%)
I: (52.4±15.9),
C: (54.0±12.7)
5
I:5
BDI
I: 24.2 (9.7)
C: 27.3 (10.7)
Cukor (2014) [32] RCT age>18
HD>6 months
depression scale
BDI-II >10
59 (33/26)
Male: 16 (27%)
Not reported 6
Not reported the
detailed dropout
rates in each group
BDI-II
I: 24.7 (9.8)
C: 21.9 (8.9)
HAM-D
I: 15.7 (6.8)
C: 12.9 (5.3)
Lerma (2017) [30] RCT age>18
HD>6 months
BDI: mild or
moderate scores
49 (31/18)
Male: 23 (47%)
I: (41.8±14.7)
C:(41.7±15.1)
11
I:7
C:4
BDI
I: 13.6 (7.6)
C: 15.8 (10.0)
Valsara (2016) [33] RCT age:20-65
HD>1 year
HADS score>7
67 (33/34)
Male: 47 (70.2%)
66.67% in 43 to
65 years of age,
13 HADS
I: 11.85 (2.15)
C: 11.21 (2.53)
Mehrotra (2019) [34] RCT age≥21
HD ≥3 months
BDI-II score≥15
114 (56/58)
Male: 68 (57%)
I: (50±13),
C:(53±12)
6
I:45
C:2
QIDS-C
I: 12.2 (5.1)
C: 10.9 (4.9)
Al saraireh (2018) [35] RCT HD>1 year
Hamilton depression
rating scale
105 (51/54)
Male: 52 (50%)
I: (53.4±8.0)
C:(52±10.7)
25
I: 11
C:14
HAM-D
I: 19.5 (5.4)
C: 19.6 (5.4)
I intervention group, C comparison
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(MD = − 4.37, 95% CI − 9.90 to 1.16, p = 0.008). Statisti-
cally significant heterogeneity was found in this analyse
(I2 = 79%).
Three studies reported the depressive scores at follow-
up (Fig. 5). Lerma et al.’s [30] study reported the signifi-
cant difference (MD = -7.6, 95%CI − 12.75 to − 2.45)
between two groups during the 4 weeks follow-up after
treatment. Similarly, in Duarte et al.’s [31] study, the dif-
ference between CBT compared with usual care was also
be found during the 6 months follow-up after
treatment (MD = -6.8, 95%CI − 11.07 to − 2.53). In
contrast, in Cukor et al.’s [32] study, there was a
non-significant effect in reducing the depression
symptoms between the CBT and usual care during
the 3 months follow-up. (Fig. 5).
Improvement in QoL
Three studies demonstrated QoL outcomes between
CBT with usual care. Duarte et al.’s [31] study stated
that CBT had a positive effect of improving the mental
component summary in the KDQOL scale (P<0.001 in
the CBT group, P = 0.451 in usual care group), whilst
the difference in physical component summary in the
Table 2 Characteristics of the included studies
Study ID Intervention group Comparison group Outcome Measures Follow up
Duarte
(2009) [31]
Group CBT:12 weekly sessions (4 participants per group)
1 hour each session
(1) self-monitoring of mood status
(2) cognitive restructuring
(3) pleasant activities
(4) social abilities
(5) relaxation exercises with positive imagination
Delivered by a licenced psychologist
Usual care depression
QoL
BDI
MINI
KDQOL-SF
6 months after
treatment
Cukor
(2014) [32]
Individual chairside CBT:12 weekly sessions
1 hour each session
(1) assessment
(2) psychoeducation of depression and medical illness
(3) behavioural activation,
(4) cognitive intervention
Delivered by a doctoral-level psychologist
Usual care (waiting list) depression
QoL
BDI-II
HAM-D
KDQOL-SF
3 months after
treatment
Lerma
(2017) [30]
Group CBT: 5 weekly sessions (3-6 participants per group)
2 hours each session
(1) Behavioural activation
(2) Deep breathing and muscle relaxation
(3) Cognitive restructuring
Delivered by: Therapist
Usual care (waiting list) depression
QoL
BDI
CIQOLP
1month after
treatment
Valsara
(2016) [33]
Individual CBT: 10 weekly sessions
1 hour each session
(1) Behavioural activation
(2) Cognitive restructuring
(3) Didactic techniques
Delivered by a doctoral-level nurse with CBT training
Non-directed counselling depression HADS 3months after
treatment
Mehrotra
(2019) [34]
Individual CBT: 10 weekly sessions
1 hour each session
(1) psychoeducation
(2) behavioural activation,
(3) cognitive intervention
(4) health behavioural modification
Delivered by the therapists.
Sertraline depression
QoL
QIDS-C
BDI-II
Global quality
of life scale
Not reported
Al saraireh
(2018) [35]
Individual CBT: 7sessions
1 hour each session
(1) Familiarization with CBT (sessions 1 and 2).
(2) Active treatment (sessions 3 to 6), where
we applied the
specific CBT interventions.
(3) Relapse prevention
Delivered by nurses who had CBT expertise
Psychoeducation
7 sessions for one hour
each time
disease education,
treatment education,
stress management, relaxation
techniques, positive thinking,
optimism, deep breathing,
problem-solving skills
Depression HDRS Not reported
BDI Beck depression inventory, BDI-II Beck depression inventory II. MINI: Mini International Neuropsychiatric interview, HADS Hospital anxiety and depression scale,
HDRS Hamilton depression rating scale, QIDS-C Quick Inventory of Depressive Symptoms-Clinician-rated, KDQOL-SF Kidney disease and quality of life-short form,
QIDS-C Quick inventory of depressive symptoms-clinician-rated, CIQOLP Chronic Ill Quality of Life Profile
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KDQOL scale was not significant (P = 0.577 in the CBT
group, P = 0.604 in the control group).
Lerma et al.’s [30] study showed a significant differ-
ence between the CBT and usual care on QoL at post-
treatment and 5 weeks follow-up (SMD = 0.73, 95%CI
0.13 to1.33; SMD = 0.89, 95%CI 0.28 to1.50). In contrast,
in Cukor et al.’ [32] study, no statistically significant dif-
ferences were found at post-treatment and follow-up.
CBT vs non-directed counselling
One study (67 participants) contributed to this outcome
[33]. Compared to baseline, the two groups all decreased
depression level from moderate to mild. Nevertheless,
the difference in depression scores between the CBT
group and the non-directed counselling was significant,
favouring CBT. (MD -2.39, 95%CI − 3.49 to − 1.29).
Similarly, there was also a significant difference (MD
-3.01, 95%CI − 4.06 to − 1.96) after 3 months of follow-
up. This study did not investigate the QoL outcome at
post-treatment or follow-up.
CBT vs antidepressant
Mehrotra et al.’s [34] study (114 participants) compared
the effectiveness between CBT and sertraline, and the
depression symptoms were measured by QIDS-C. The
two groups all showed significant effects in reducing de-
pressive symptoms from moderate to mild. However, the
results demonstrated that sertraline groups were more
effective than CBT in reducing depressive symptoms im-
mediately post-treatment (MD 2.2, 95%CI 0.43 to 3.97).
The follow-up data of depressive symptoms was not re-
ported. Regarding the QoL, the difference in QoL im-
provement between the CBT group and sertraline group
was non-significant (Effect estimate with 95% CI: − 0.6
(− 0.2 to 1.4)).
Fig. 2 Risk of bias graph: review authors’ judgements about each risk of bias item presented as percentages across all included studies
Fig. 3 Risk of bias summary: review authors’ judgements about each
risk of bias item for each included study. Detailed legend: Read the
main text --Results of study quality assessment (Page 19–20)
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CBT vs psychoeducation
Only Al saraireh et al.’s [35] study (105 participants) re-
ported that psychoeducation reduced the HAM-D score
significantly compared to CBT (MD 3.9, 95%CI 2.27 to
5.52). Compared to baseline, the severity of depression
in the psychoeducation group decreased from severe to
moderate, while the severity of depression in CBT group
did not change. The change of depression scores at
follow-up and QoL were not reported in their study.
Discussion
Summary of the main findings
All studies showed that depressive symptoms improved
with CBT. Upon a closer look, the results demonstrated a
beneficial effect of CBT on depressive symptoms and QoL
when compared to usual care and non-directive
counselling. It also stated that CBT was less effective than
sertraline and psychoeducation in improving depressive
symptoms.
Discussion of the main findings
Depression
CBT vs usual care
CBT seems to be more effective than usual care in allevi-
ating depression. As mentioned before, three studies
compared CBT with usual care, and they were varied in
the quality of the evidence and results. Duarte et al.’s
[31] study had the least risk of bias among these three
studies (only had performance bias, which was unavoid-
able in conducting CBT). Given the strong evidence
from Duarte et al.’s study, CBT appears to more effective
than usual care in improving depressive symptoms.
Table 3 Effect of intervention and control groups for HD on symptoms of depression and QoL at post-treatment and follow-up
Study ID Time-point Depression QoL
Measure Intervention Control MD/SMD (95% CI) Measure Intervention Control MD/SMD (95% CI)
Duarte
(2009) [31]
post-treatment BDI 14.1 (8.7) 21.2 (9.1) MD: -7.1 (-10.88, -3.32) KDQOL Only sub-dimensions scores of the scale were
reported
follow-up
(6 mon)
10.8 (8.8) 17.6 (11.2) MD: -6.8 (-11.07, -2.53)
Cukor
(2014) [32]
post-treatment BDI-II 11.7 (9.8) 14.5 (8.5) MD: -2.8 (-7.47,1.87) KDQOL 115.3 (25.5) 110.6 (25.1) SMD: 0.18(-0.33,0.70)
follow-up
(3 mon)
9.9 (8.5) 9.1 (6.5) MD:0.8 (-3.03,4.63) 118.3 (27.7) 119.7 (24.7) SMD: -0.05(-0.57,0.46)
post-treatment HAM-D 6.5 (6.8) 10.9 (5.4) MD: -4.4 (-7.51, -1.29) - - - -
follow-up
(3 mon)
6.7 (5.8) 5.0 (4.3) MD:1.7 (-0.87,4.27) - - - -
Lerma
(2017) [30]
post-treatment BDI 10.2 (8.2) 15.0 (10.9) MD: -4.8 (-10.6,1.00) CIQOLP 109.6 (21.1) 94.0 (21.0) SMD: 0.73 (0.13,1.33)
follow-up
(1 mon)
7.1 (7.2) 14.7 (9.7) MD: -7.6 (-12.7, -2.45) 112.5 (23.8) 91.3 (22.5) SMD: 0.89 (0.28,1.50)
Valsara
(2016) [33]
post-treatment HADS 6.82 (1.86) 9.21 (2.69) MD: -2.39 (-3.49, -1.29) Not reported
follow-up
(3 mon)
6.73 (1.53) 9.74 (2.71) MD: -3.01 (-4.06, -1.96)
Mehrotra
(2019) [34]
post-treatment QIDS-C 8.1 (5.1) 5.9 (4.5) MD:2.2 (0.43,3.97) GQOL 5.6 (5.0 to 6.2) 6.4 (5.8 to 7.0) -
Al saraireh
(2018) [35]
post-treatment HADS 15.0 (5.5) 11.1 (2.3) MD:3.9 (2.27,5.52) Not reported
Fig. 4 Forest plot of CBT vs usual care in the reduction of depressive symptoms after post-treatment. Detailed legend: Read the main text
--Effects of the intervention (Page 22–23)
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Due to the sparse experiments on this topic, globally,
there is no specific guidance of depression in HD
patients. However, the finding of the present review is
relatively consistent with the NICE guideline [18] on
chronic disease patients with depression. This guideline
recommends CBT for mild to moderate depression pa-
tients with a chronic illness condition [18]. Similarly, this
finding is in line with the systematic review [19] indicat-
ing that CBT was more effective than usual care in heart
failure patients with depression.
However, in the current review, it seems that HD pa-
tients with depression did not benefit from short-term
CBT. In Lerma et al.’s [30] study, after 5 weeks CBT, the
depressive score between the two groups did not show
statistically significant difference. The possible reason
might be that depression is a chronic condition; patients
could not recover with limited psychological treatments.
Likewise, NICE guidelines [18] also suggest that nine to
12 weeks CBT were needed for chronic disease patients
with depression. However, the result of Lerma et al.’s
(2014) study needs to be interpreted with caution due to
the small sample size and relatively low quality of the
evidence.
Interestingly, in the present review it was also
found that CBT has a long-term sustainable effect
among HD patients with depression. In Duarte
et al.’s [31] study, at 6 months follow-up after the
treatment of CBT, the depression scores decreased
in CBT group and showed a significant difference
between the comparison and intervention groups.
This point is also supported by Cuijpers, Hollon
[36]. The possible reasons for this effect could be
explained in that patients in CBT groups are taught
the skills and knowledge to identify maladaptive
thinking and deal with the depressive symptoms.
Since the patients were equipped with the coping
strategies, they could take preventative methods to
alleviate depressive symptoms [37]. Indeed, one of
the aims of CBT is to empower clients to become
their own therapist [17]. In that way, CBT could
help patients prevent depression recurrence [38].
CBT vs counselling
In the present review, one study showed that CBT was
more effective than non-directive counselling at post-
treatment and 3 months of follow-up in HD patients
[33]. The possible reasons for this result might be the
different strategies used between CBT and counselling.
CBT is task-oriented, focusing on changing the clients’
thinking and behaviour patterns, and finding solutions
to the practical issues. In contrast, counselling is less dir-
ective. Counsellors use active listening and empathetic
attitude strategies to help the patients to understand
themselves better [39]. Valsara et al.’s [33] result sup-
ports the statements of NICE guidelines for depression
in adults [18]. In this guideline, CBT is recommended as
a frontline treatment, while counselling is suggested as a
second-line intervention.
However, in recent years, a growing number of studies
suggest that CBT and counselling have comparable ef-
fects [40, 41]. Therefore, it is unknown whether the rec-
ommendations of NICE guidance would be revised
based on these current studies. As the number of studies
on this topic was sparse, and the quality of Valsaraj
et al.’s [33] study was not high, there is no firm conclu-
sion for these two therapies. Hence, better-designed
RCTs which improve on the methodology used by
Valsaraj et al.’s study are needed in the future. However,
evidence-based medicine is not only about the effective-
ness of the intervention but also the preferences of the
patients where possible [42]. Therefore, further studies
could conduct not only quantitative studies to investi-
gate the effectiveness of these two therapies but also
qualitative research to explore the preferences and expe-
riences of HD patients in these two kinds of
psychotherapies.
CBT vs sertraline
It is noteworthy that, in the present review, the newest
study conducted by Mehrotra et al. [34] reported that
sertraline was slightly more effective than CBT in HD
patients with moderate depression. Mehrotra et al.’s [34]
study had a relatively high methodological quality. The
Fig. 5 Forest plot of CBT vs usual care in the reduction of depressive symptoms after follow-up. Detailed legend: Lerma et al.’s [28] study
reported the significant difference (MD = -7.6, 95%CI − 12.75 to − 2.45) between two groups during the 4 weeks follow-up after treatment.
Similarly, in Duarte et al.’s [29] study, the difference between CBT compared with usual care was also be found during the 6 months follow-up
after treatment (MD = -6.8, 95%CI − 11.07 to − 2.53). In contrast, in Cukor et al.’s [30] study, there was a non-significant effect in reducing the
depression symptoms between the CBT and usual care during the 3 months follow-up
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multicentre design could balance the confounding fac-
tors, promoting generalisation. Moreover, compared to
other studies in this review, the depressive symptoms in
their studies are measured by clinician-rated validated
depression scale. This could increase the reliability of
the outcome measurements.
This finding is consistent with an RCT, which com-
pared the effectiveness of CBT with sertraline in diabetes
patients with depression [43]. In comparison to CBT,
the rapid therapeutic effect is the most advantageous to
antidepressants. However, compared to diabetes pa-
tients, the safety of the antidepressants should be
emphasised among HD patients due to their limited
renal function and the possibility of drug-drug interac-
tions. Indeed, in Mehrotra et al.’s [34] study, the rates of
adverse events were higher in the sertraline group.
Therefore, for moderate depressive HD patients, both
treatments could be considered, while the pharmaco-
logical therapies need to be taken into account carefully.
In addition, for HD patients with severe depression,
the combination of CBT with antidepressants is worthy
to further investigation. According of NICE (2009) [18],
the guideline suggests that CBT with antidepressants
can be utilised among severe depression patients with a
chronic illness. However, most of the participants in the
present systematic review were diagnosed with moderate
depression. Hence, further study could investigate the ef-
ficacy of the combined function of CBT with
antidepressants.
QoL
Regarding QoL, CBT might have a positive influence in
improving QoL. In the present review, four studies all
showed that the QoL scores increased after the CBT
when comparing to baseline QoL scores. However, com-
paring CBT with usual care and sertraline, different re-
sults were reported. Owing to the varied number of risk
of biases of these four studies, the present author could
not reach a convincing conclusion. Nevertheless, consid-
ering the methodological quality of Duarte et al.’s [31]
study is higher than the other three studies, CBT could
be suggested as an effective treatment in improving QoL
among HD patients with comorbid depression.
The applicability of evidence
The scope of the current systematic review was limited
to adult HD patients with depressive symptoms. The lit-
erature on therapy for depression in paediatric HD was
not reviewed. Furthermore, the majority of the adult pa-
tients were middle-aged population, which was inappro-
priate to apply the conclusion to the geriatric HD
patients with depression. Lastly, most of the participants
included in the present systematic review were assessed
as having moderate depression. Hence, the conclusions
of the current review may not be applicable to HD pa-
tients with severe depression.
The applicability of CBT
Given that CBT could be considered as an efficient, safe
treatment option for HD patients, renal department
healthcare providers should consider CBT as a treatment
option. According to Goh et al. (2018) [7], the CBT
might hard to embed in standard care in terms of insuf-
ficient access for participants to this therapy and limited
CBT providers [44]. Hence, the present author discussed
the solutions of this issue in two ways, which is elabo-
rated as follows.
Internet-based CBT can be considered as an effective
treatment for HD patients with depression. In the
present review, all studies used traditional face-to-face
CBT. Barriers of face-to-face CBT include geographic
distance, limited professional therapists and high cost of
therapy [45]. To bridge these treatment gaps, Internet-
based CBT has been proved as one kind of methods to
resolve the barriers mentioned above. Furthermore, ac-
cording to an updated meta-analysis conducted by
Carlbring et al. [46], internet-guided CBT and traditional
face-to-face CBT have equivalent effects. However, for
HD patients with comorbid depression, there was an ab-
sence of evidence which used internet-based CBT.
Therefore, further study could investigate this type of
CBT in HD patients.
Nurses can be considered as deliverers of CBT. Gener-
ally, CBT is conducted by professional therapists or psy-
chologists. Interestingly, one study conducted in the US
after hurricanes Katrina and Rita demonstrates that CBT
may not need to be performed by psychologists. In their
research, twenty-two social workers used CBT to care
ESRD patients after the disaster. The depressive symp-
toms were significantly improved after the therapy [47].
Truly, in the present review, two of the included studies
showed that the CBT which was conducted by nurses
also had a promising effect on decreasing depression
scores. Likewise, an RCT with 279 chronic obstructive
pulmonary disease patients with diagnosed anxiety, a
nurse-led CBT has been proved to be a clinically and
cost-effective treatment to alleviate anxiety symptoms
[48]. Therefore, further study could investigate the ef-
fectiveness of nurse-led CBT in HD patients.
Strengths and limitation of this systematic review
Only HD patients diagnosed with depressive symptoms
were included in the present review. This is inconsistent
with the previous three relevant systematic reviews [22,
23, 49] which failed to include participants diagnosed
with depressive symptoms at baseline. The number of
included studies was decreased due to this rigorous
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criterion. Nevertheless, the conclusions of the present
review serve the most relevant population.
Only six RCTs with 479 participants were included in
the current systematic review; the handful quantity of
studies and small sample size limited generalisation. Sec-
ondly, the diagnostic criteria of depression, the definition
of CBT components, format, duration, as well as the
outcome measurements were varied in included studies.
Thirdly, the quality of the included studies was varied.
Only one study was rated as low risk of bias in most of
the domains. Therefore, firm conclusions could not be
identified due to the reasons above.
Fourth, most of the outcome measurements (depres-
sion and QoL) were self-reported questionnaires, which
involved patients’ subjective feeling; this may also pro-
duce biases. In addition, publication bias might be gen-
erated due to merely English articles were included in
the present review. Lastly, there were insufficient studies
that investigated the long-term maintained effects of
CBT. Only one study assessed the depressive symptoms
and QoL at 6 months follow-up. Therefore, the long-
lasting effect of CBT was unknown.
Implications for practice
Depression screening and early intervention of depres-
sion might be essential in routine HD nursing. In the
current review, the present author found that most of
the included patients had moderate depression at base-
line, while the proportion of mild depression patients
was small. This condition indicates that healthcare pro-
viders need to find approaches to prevent depressive
symptoms from deteriorating in the early stage of de-
pression. Hence, screening and integrating the know-
ledge and skills of CBT with patients’ education might
be an effective way to improve HD patients’ well-being.
Implications for future research
At present, the quality and number of studies investi-
gated in this field were insufficient. Therefore, more
rigorous studies comparing the CBT with usual care and
other treatments (for example, antidepressant) in HD
patients with depression are needed in the future. In
terms of the methodological quality or the existing evi-
dence, future studies can focus on recruiting larger sam-
ple size, utilising allocation concealment and recruiting
blinded outcome assessors to improve the quality of the
studies. In regard to the gaps of the present review, fu-
ture research can work toward the different approaches
in CBT among HD patients with depression, such as
internet-based CBT, CBT combined with antidepres-
sants or nurse-led CBT. Additionally, more studies
should focus on the long-term effects of CBT on depres-
sive symptoms and QoL.
HD patients diagnosed with depression could be inves-
tigated in the future. Generally, depression should be di-
agnosed by professionals according to the Diagnostic
and Statistical Manual of Mental Disorders, Fifth Edition
(DSM-5). In the present review, none of the participants
was diagnosed with depression according to DSM; most
of them are screened by different depression question-
naires. Duarte et al’ s research used the MINI Inter-
national Neuropsychiatric Interview to screen out the
participants instead of depression questionnaires. How-
ever, MINI is applied to meet the need for a short but
accurate structured psychiatric interview for multicentre
clinical trials and epidemiology studies and to be used as
the first step in outcome tracking in non-research clin-
ical settings [50, 51]. Thus, MINI should not be used to
officially diagnose depression. Given this status, the
present author suggests that researchers could pay atten-
tion to this type of person.
Conclusions
In summary, CBT has shown an encouraging effect on
depressive symptoms and mental summary of QoL
among HD patients with depressive symptoms. Twelve
weeks of intervention can be recommended in HD clin-
ical practice. However, due to the mixed quality and
small quantity of the existing studies, firm conclusions
were prevented.
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